Brief: FDA Grants SeaStar Medical’s Selective Cytopheretic Device Breakthrough Device Designation For Hepatorenal Syndrome

SeaStar Medical Holding

18/10/2023 13:34

Oct 18 (Reuters) - SeaStar Medical Holding Corp  ICU.O :
    * FDA GRANTS SEASTAR MEDICAL’S SELECTIVE CYTOPHERETIC DEVICE
BREAKTHROUGH DEVICE DESIGNATION FOR HEPATORENAL SYNDROME
    * FDA GRANTS SEASTAR MEDICAL’S SELECTIVE CYTOPHERETIC DEVICE
BREAKTHROUGH DEVICE DESIGNATION FOR HEPATORENAL SYNDROME

Source text for Eikon:  ID:nGNX7qpF4K 
Further company coverage:  ICU.O 

 ((Reuters.Briefs@thomsonreuters.com;))